Why Praxis Precision Medicines Stock Popped Today
Source: Motley Fool
2025-12-29 19:39:47 ET
Shares of Praxis Precision Medicines (NASDAQ: PRAX) leaped on Monday after the clinical-stage biopharmaceutical company received a Breakthrough Therapy Designation (BTD) for its experimental tremor treatment.
By the close of trading, Praxis' stock price was up more than 13%.
Image source: Getty Images.
Praxis Precision Medicines Inc.
NASDAQ: PRAX
PRAX Trading
7.19% G/L:
$319.25 Last:
168,187 Volume:
$305.79 Open:
PRAX Latest News
March 09, 2026 09:54:00 am
Neuropsychiatric Innovation Draws Big Pharma Interest and Fresh Investment
March 04, 2026 04:01:00 pm
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2026 01:49:01 pm
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year
February 22, 2026 02:36:11 pm
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million
PRAX Stock Data
$8,057,264,446
20,105,683
0.7%
83
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
